⌘K

Login Start Free

Home/Filings/4/0000950170-24-031815

4//SEC Filing

Cigler Tessa 4

Accession 0000950170-24-031815

CIK 0001488039other

View on SEC.gov Company Profile

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 8:35 PM ET

Size

5.3 KB

Accession

0000950170-24-031815

Insider Transaction Report

Form 4

Period: 2024-03-09

ATOSSA THERAPEUTICS, INC.ATOS

Director

Transactions

Award
Stock Option (right to buy)
2024-03-09+20,834→ 20,834 total
Exercise: $1.09Exp: 2034-03-09→ Common Stock (20,834 underlying)

Footnotes (1)

[F1]The options shall vest in four equal quarterly installments following March 9, 2024, subject to the Reporting Person's continued service through each applicable date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

ATOSSA THERAPEUTICS, INC.

CIK 0001488039

Entity typeother

Related Parties

1

filerCIK 0002015142

Filing Metadata

Form type: 4
Filed: Mar 13, 8:00 PM ET
Accepted: Mar 14, 8:35 PM ET
Size: 5.3 KB

View on SEC.gov